BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36357702)

  • 1. Dietary sodium restriction prevents vascular endothelial growth factor inhibitor-induced hypertension.
    van Doorn L; Visser WJ; van Dorst DCH; Mirabito Colafella KM; Koolen SLW; de Mik AVE; Garrelds IM; Bovée DM; de Hoop EO; Bins S; Eskens FALM; Hoorn EJ; Jan Danser AH; Mathijssen RHJ; Versmissen J
    Br J Cancer; 2023 Jan; 128(2):354-362. PubMed ID: 36357702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment and Implications of Vascular Endothelial Growth Factor Inhibitor-Induced Blood Pressure Rise: A Clinical Cohort Study.
    van Dorst DCH; Kabadayi S; Oomen-de Hoop E; Danser AHJ; Mathijssen RHJ; Versmissen J
    J Am Heart Assoc; 2023 Jan; 12(1):e028050. PubMed ID: 36583425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review of the risk of adverse outcomes associated with vascular endothelial growth factor inhibitors for the treatment of cancer.
    Faruque LI; Lin M; Battistella M; Wiebe N; Reiman T; Hemmelgarn B; Thomas C; Tonelli M
    PLoS One; 2014; 9(7):e101145. PubMed ID: 24988441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension due to antiangiogenic cancer therapy with vascular endothelial growth factor inhibitors: understanding and managing a new syndrome.
    Small HY; Montezano AC; Rios FJ; Savoia C; Touyz RM
    Can J Cardiol; 2014 May; 30(5):534-43. PubMed ID: 24786444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review and meta-analysis of the effect of intravitreal VEGF inhibitors on cardiorenal outcomes.
    Lees JS; Dobbin SJH; Elyan BMP; Gilmour DF; Tomlinson LP; Lang NN; Mark PB
    Nephrol Dial Transplant; 2023 Jun; 38(7):1666-1681. PubMed ID: 36318455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary sodium restriction reverses vascular endothelial dysfunction in middle-aged/older adults with moderately elevated systolic blood pressure.
    Jablonski KL; Racine ML; Geolfos CJ; Gates PE; Chonchol M; McQueen MB; Seals DR
    J Am Coll Cardiol; 2013 Jan; 61(3):335-43. PubMed ID: 23141486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal thrombotic microangiopathy and nephrotic proteinuria induced by intravitreal injection of aflibercept for diabetic macular edema.
    Kikuchi Y; Odashima Y; Yoshikawa K; Oda T; Tanaka F; Oikawa H; Ishigaki Y; Asahi K
    BMC Nephrol; 2022 Oct; 23(1):348. PubMed ID: 36309669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-VEGF Anticancer Drugs: Mind the Hypertension.
    Katsi V; Zerdes I; Manolakou S; Makris T; Nihoyannopoulos P; Tousoulis D; Kallikazaros I
    Recent Adv Cardiovasc Drug Discov; 2014; 9(2):63-72. PubMed ID: 26123049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of dietary potassium chloride on hemodynamics of Dahl salt-sensitive rats in response to chronic administration of sodium chloride.
    Manger WM; Simchon S; Stier CT; Loscalzo J; Jan KM; Jan R; Haddy F
    J Hypertens; 2003 Dec; 21(12):2305-13. PubMed ID: 14654751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low dialysate sodium levels for chronic haemodialysis.
    Dunlop JL; Vandal AC; Marshall MR
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD011204. PubMed ID: 30646428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor receptor inhibitor enhances dietary salt-induced hypertension in Sprague-Dawley rats.
    Gu JW; Manning RD; Young E; Shparago M; Sartin B; Bailey AP
    Am J Physiol Regul Integr Comp Physiol; 2009 Jul; 297(1):R142-8. PubMed ID: 19420288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dietary sodium restriction on human urinary metabolomic profiles.
    Jablonski KL; Klawitter J; Chonchol M; Bassett CJ; Racine ML; Seals DR
    Clin J Am Soc Nephrol; 2015 Jul; 10(7):1227-34. PubMed ID: 25901092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renin-Angiotensin-Aldosterone System Modulates Blood Pressure Response During Vascular Endothelial Growth Factor Receptor Inhibition.
    Bottinor WJ; Shuey MM; Manouchehri A; Farber-Eger EH; Xu M; Nair D; Salem JE; Wang TJ; Brittain EL
    JACC CardioOncol; 2019 Sep; 1(1):14-23. PubMed ID: 32984850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ACE inhibition on cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on a high-sodium diet.
    Mervaala E; Lassila M; Vaskonen T; Krogerus L; Lähteenmäki T; Vapaatalo H; Karppanen H
    Blood Press; 1999; 8(1):49-56. PubMed ID: 10412883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Captopril attenuates hypertension and renal injury induced by the vascular endothelial growth factor inhibitor sorafenib.
    Nagasawa T; Hye Khan MA; Imig JD
    Clin Exp Pharmacol Physiol; 2012 May; 39(5):454-61. PubMed ID: 22443474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of high salt diet on blood pressure and renal damage during vascular endothelial growth factor inhibition with sunitinib.
    Lankhorst S; Baelde HJ; Clahsen-van Groningen MC; Smedts FM; Danser AH; van den Meiracker AH
    Nephrol Dial Transplant; 2016 Jun; 31(6):914-21. PubMed ID: 26681729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of longer-term modest salt reduction on blood pressure.
    He FJ; Li J; Macgregor GA
    Cochrane Database Syst Rev; 2013 Apr; (4):CD004937. PubMed ID: 23633321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid development of hypertension and proteinuria with cediranib, an oral vascular endothelial growth factor receptor inhibitor.
    Robinson ES; Matulonis UA; Ivy P; Berlin ST; Tyburski K; Penson RT; Humphreys BD
    Clin J Am Soc Nephrol; 2010 Mar; 5(3):477-83. PubMed ID: 20056761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal vascular endothelial growth factors hypertension, proteinuria, and renal injury: a concise review.
    Hanna RM; Ahdoot RS; Kim MS; Jhaveri KD; Kalantar-Zadeh K; Kurtz IB
    Curr Opin Nephrol Hypertens; 2022 Jan; 31(1):47-56. PubMed ID: 34750330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daily exercise attenuates the development of arterial blood pressure related cardiovascular risk factors in hypertensive rats.
    Collins HL; Rodenbaugh DW; DiCarlo SE
    Clin Exp Hypertens; 2000 Feb; 22(2):193-202. PubMed ID: 10744359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.